Scientific Sessions 2025  /  Finding Common Ground: Controversies in PAD and CLTI Management  /  Is Microvascular disease the silent killer for PAD patients?
Logo

American Heart Association

  29
  0

Final ID:

Is Microvascular disease the silent killer for PAD patients?

  • Beckman, Joshua  ( UT Southwestern , Dallas , Texas , United States )
  • Sullivan, Alexander  ( Vanderbilt University Medical Center , Nashville , Tennessee , United States )
    • Author Disclosures:
    Joshua Beckman: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Tourmaline:Active (exists now) ; Consultant:Regeneron:Active (exists now) ; Consultant:Novo Nordis:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Minsight:Active (exists now) ; Consultant:Merck:Active (exists now) | Alexander Sullivan: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Finding Common Ground: Controversies in PAD and CLTI Management

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
"When is Enough Enough? No option CLTI patient"

Dua Anahita, Clair Dan

Endo vs Open: How should BASIL-2 and BEST-CLI impact practices?

Findeiss Laura, Mcginigle Katharine

More abstracts from these authors:
Opportunities for contribution to AHA guideline writing, council engagement

Beckman Joshua

Platelet Activation in Patients with Peripheral Artery Disease From 43 Sites: Assessment of Samples Transported by Overnight Mail

Stubblefield William, Sullivan Alexander, Amin Taneem, Boutaud Olivier, Cahill Katherine, Flaherty David, Matlock Brittany, Berger Jeffrey, Beckman Joshua

You have to be authorized to contact abstract author. Please, Login
Not Available